Insight Companies

Coronary Stent Market Key Players, Trends and Growth Analysis

Coronary Stent Market Size and Leading Companies

The coronary stent market was valued at USD 8.99 billion in 2023 and is projected to reach USD 12.51 billion by 2032, growing at a steady compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5152

Report Highlights:

  • Drug-eluting stents (DES) held the largest market share in 2023, accounting for 60%.
  • North America led the global market in 2023 with a 37% share.
  • Bioresorbable Scaffold Systems (BRS) are expected to be the fastest-growing segment, with a projected 5.2% CAGR during the forecast period.
  • Coronary stents are primarily used for treating coronary artery disease (CAD), which remains the main driver of market growth.

Coronary stents are medical devices commonly used in angioplasty procedures to treat blocked coronary arteries caused by coronary artery disease (CAD). CAD occurs when plaque builds up in the coronary arteries, restricting blood flow to the heart, which can lead to chest pain, heart attacks, and heart failure. Stents are small, expandable mesh tubes inserted into these narrowed arteries to keep them open and improve blood circulation.

The coronary stent market emerged in the late 1980s with the introduction of balloon-expandable stents, which revolutionized the treatment of CAD. Prior to stent technology, bypass surgery was the primary treatment option, but it was invasive. Today, coronary stents are primarily used in percutaneous coronary intervention (PCI), also known as angioplasty with stenting. This minimally invasive procedure uses catheters to place stents in the blocked arteries, offering a less invasive solution to treat CAD.

Coronary Stent Market Companies:

  • Biotronik SE & Co. KG: A leading medical technology company, Biotronik specializes in cardiovascular devices, including coronary stents, and is known for its innovative solutions in heart disease treatment.
  • Cook: Cook is a global healthcare company offering a wide range of medical devices, including coronary stents, with a strong focus on improving patient outcomes in cardiovascular care.
  • Terumo Corporation: Based in Japan, Terumo is a major player in the medical device industry, providing cutting-edge coronary stents and other cardiovascular products designed to enhance clinical outcomes.
  • Abbott: A global healthcare leader, Abbott is well-known for its coronary stent offerings, particularly in the drug-eluting stent segment, and is committed to advancing heart disease treatments.
  • BD (Becton, Dickinson and Company): BD is a global medical technology company that manufactures a range of healthcare solutions, including coronary stents, aimed at improving cardiovascular health.
  • MicroPort Scientific Corporation: A leading global medical device manufacturer, MicroPort focuses on providing innovative solutions for cardiovascular care, including high-quality coronary stents.
  • B. Braun Melsungen AG: A trusted name in the medical industry, B. Braun offers advanced coronary stent solutions as part of its broad range of cardiovascular and other healthcare products.
  • Boston Scientific Corporation: Boston Scientific is a well-established player in the coronary stent market, offering a variety of stents, including drug-eluting options, and is committed to advancing heart disease treatment.
  • Medtronic: As one of the largest medical device companies globally, Medtronic provides a wide array of coronary stent solutions, helping to treat coronary artery disease with minimally invasive procedures.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/coronary-stent-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5152

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.

Recent Posts

Kedrion Biopharma’s COAGADEX® Receives FDA Orphan Drug Designation for Acquired Factor X Deficiency (AFXD)

Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More

5 hours ago

Benecard PBF and DecisionRX Join Forces to Personalize and Optimize Pharmacy Benefits

enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More

5 hours ago

Four Resilient Biotech Companies Making Waves in a Challenging Market

In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More

5 hours ago

Natera Launches TEODOR Trial in Partnership with ABCSG to Advance Personalized Breast Cancer Treatment

cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More

5 hours ago

Interventional Radiology Market: Size, Growth, and Leading Companies Driving Innovation

The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More

9 hours ago

Physical Therapy Market Growth and Leading Companies Driving Innovation

The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More

10 hours ago